GTCR Forms Pharma Acquisition Platform

GTCR has formed Actient Pharmaceuticals LLC, a Deerfield, Ill.-based platform to acquire and operate specialty pharmaceutical companies and products. GTCR will invest up to $200 million in Actient, which will be run by former Abbott Labs executive Ed Fiorentino.

23 March 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles